Skip to main content
OpenTrials
Completed

NCT Number: NCT06654362

The Effect of Multimodal Nutrition Intervention on Glucose and Lipid Parameters of Arfa Iron and Steel Company Workers

The goal of this clinical trial is to investigate the impact of nutritional interventions on glycemic and lipid profile factors among workers.

The main questions it aims to answer are:

Does nutritional interventions (include: nutritional education and Change in the Factory Restaurant's Menu improve glycemic and lipid profile factors among workers? Researchers will compare glycemic and lipid profile factors among workers before and after nutritional intervention .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Blood Sugar Body Weight Body Weight Changes Lipid Profile Pathological Conditions, Signs and Symptoms Signs and Symptoms Weight Change

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Shahid Sadoughi University of Medical Sciences

Yazd, Iran

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • be Arfa's company worker

Exclusion criteria

  • individuals who were diagnosed with any type of cancer

Treatment and study plan

nutritional interventions include education and modifying company's restaurant menu

Behavioral
  • Reducing fried foods and replacing them with healthier alternatives.
  • Decreasing the consumption of sweetened beverages such as soda and replacing them with yogurt.
  • Reducing the intake of refined grains and substituting with whole grains.
  • Increasing fruit intake.
  • Increasing the intake of vegetables as much as possible.
  • Organizing face-to-face educational sessions with the chef to train them and improve cooking methods, to reduce fat and oil intake.

Primary outcomes

  1. Total Cholesterol, mg/dL

    Time frame: From enrollment to the end of intervention at 6 months

  2. Total triglycerides, mg/dL

    Time frame: From enrollment to the end of intervention at 6 months

  3. Low-density lipoprotein, mg/dL

    Time frame: From enrollment to the end of intervention at 6 months

  4. High-density lipoprotein, mg/dl

    Time frame: From enrollment to the end of intervention at 6 months

  5. Fast blood sugar, mg/dL

    Time frame: From enrollment to the end of intervention at 6 months

  6. serum glutamic oxaloacetic transaminase, IU/L

    Time frame: From enrollment to the end of intervention at 6 months

  7. serum glutamic pyruvic transaminase, IU/L

    Time frame: From enrollment to the end of intervention at 6 months

Sponsors and collaborators

Lead sponsor

Peyman Sarsangi

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 23, 2024
Registry last updated
Oct 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.